`Sent: Friday, October 07, 2016 6:49 PM
`To: Trials <Trials@USPTO.GOV>
`Cc: jim@carmichaelip.com; Carol Spiegel <carol@carmichaelip.com>; Flibbert, Michael
`<michael.flibbert@finnegan.com>; Queler, Maureen <Maureen.Queler@finnegan.com>
`Subject: RE: IPR2015‐01993 Request for Call with the Board
`
`Dear Mr. Kellogg,
`
`In response to your inquiry, Patent Owner seeks to file a motion to strike certain portions of Petitioner’s Reply to
`Biogen’s Opposition (Paper 46) filed September 28, 2016, and certain portions of Dr. Pleasure’s declaration (Ex.
`1045). These papers raise a new obviousness theory, i.e., the “point dose” theory, which is an improper reply. Rule
`42.23(b). Patent Owner therefore seeks a call with the Board to request authorization to file a short motion to strike as
`the Board has previously authorized. E.g., Maxlinear, Inc. v. Crest Tech. Corp., IPR2015‐00594, Paper 48 at 2 (PTAB Mar.
`18, 2016); Volkswagen Grp. of Am., Inc. v. Emerachem Holdings, LLC, IPR2014‐01555, Paper 36 at 5‐7 (PTAB Oct. 9,
`2015). Alternatively, Patent Owner requests a call to obtain the Board’s guidance on how to address the improper reply
`arguments and evidence.
`
`Please let me know if the Board would like additional information.
`
`Sincerely,
`Erin M. Sommers
`Reg. No. 60,974
`Back‐up Counsel for Patent Owner
`
`Erin M. Sommers
`Associate
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW, Washington, DC 20001-4413
`+ 202 408 4292 | fax: + 202 408 4400 | erin.sommers@finnegan.com | www.finnegan.com
`
`From: Trials [mailto:Trials@USPTO.GOV]
`Sent: Friday, October 07, 2016 3:34 PM
`To: Sommers, Erin; Trials
`Cc: jim@carmichaelip.com; Carol Spiegel; Flibbert, Michael; Queler, Maureen
`Subject: RE: IPR2015-01993 Request for Call with the Board
`
`Counsel,
`
`Can you please be more detailed about the papers you wish to file?
`
`Thanks,
`
`Andrew Kellogg,
`
`1
`
`PTAB Exhibit 3001
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`Supervisory Paralegal
`Patent Trial and Appeal Board
`USPTO
`andrew.kellogg@uspto.gov
`Direct: 571-272-5366
`
`
`
`
`From: Sommers, Erin [mailto:Erin.Sommers@finnegan.com]
`Sent: Friday, October 07, 2016 9:53 AM
`To: Trials <Trials@USPTO.GOV>
`Cc: jim@carmichaelip.com; Carol Spiegel <carol@carmichaelip.com>; Flibbert, Michael
`<michael.flibbert@finnegan.com>; Queler, Maureen <Maureen.Queler@finnegan.com>
`Subject: IPR2015‐01993 Request for Call with the Board
`
`
`Dear PTAB,
`
`I write on behalf of Patent Owner to request a conference call with the Board, during which Patent Owner plans to seek
`authorization to file a motion to strike Petitioner’s new “point dose” obviousness arguments and evidence as an
`improper reply under Rule 42.23(b).
`
`
`Patent Owner and Petitioner met and conferred and no resolution was reached. Both parties are generally available on
`Wednesday, October 12.
`
`
`Sincerely,
`Erin M. Sommers
`Reg. No. 60,974
`Back‐up Counsel for Patent Owner
`
`
`
`Erin M. Sommers
`Associate
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW, Washington, DC 20001-4413
`+ 202 408 4292 | fax: + 202 408 4400 | erin.sommers@finnegan.com | www.finnegan.com
`
`
`
`
`
`
`
`
`
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise
`exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from
`your mai box. Thank you.
`
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise
`exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from
`your mai box. Thank you.
`
`2
`
`